NEW YORK (GenomeWeb) – Oncologist group Valley Medical Oncology Consultants and Caris Life Sciences will establish a clinical molecular profiling program to serve cancer patients in the San Francisco Bay Area, they announced today.

The collaboration will use Caris Molecular Intelligence, a tumor profiling service to identify target therapies for patients based on their unique cancer biology. The service integrates molecular data generated from a patient's tumor into a report that includes biomarkers that are associated with therapies and/or available clinical trials.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: ancestry and admixture in Brazilians, characterization of novel double-stranded RNA mycovirus, and more.

Researchers report that what scents someone picks up can reflect their complement of immune genes.

The New York Times examines ethics and China's push to lead biomedical research.

At her blog, Sally Rockey dives into National Institutes of Health funding data.